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Ischemia-reperfusion damages endothelium and impairs basal production 
of nitric oxide. Basally released nitric oxide is cardioprotective by its 
inhibition of neutrophil activities. Loss of endogenous nitric oxide with 
endothelial injury may occur during two phases: cardioplegic ischemia nd 
reperfusi0n (aortic declamping). This study tested the hypothesis that 
inhibition of endogenously released nitric oxide in hearts subjected to 
regional ischemia, cardioplegic arrest, and reperfusion (1) restricts endog- 
enous cardioprotection and permits neutrophil-mediated damage and (2) 
expresses damage during the reperfusion phase. L-Nitro-arginine was used 
to block basal nitric oxide production. In 22 anesthetized ogs, the left 
anterior descending artery was ligated for 90 minutes followed by 1 hour of 
arrest with cold multidose (every 20 minutes) blood cardioplegia. Dogs were 
divided into three groups: the first group received standard unsupple- 
mented blood cardioplegia (group 1, n = 8), in the second group L-nitro- 
arginine was administered as an additive to blood cardioplegic solution (1 
mmol) and as an infusion during reperfusion (34 mg/kg) (group 2, n = 7), 
and in the third group L-nitro-arginine was administered only at reperfu- 
sion (group 3, n = 7). The ligature was released uring the second infusion 
of cardioplegic solution. Infarct size (triphenyltetrazolium chloride) was 
increased in group 3 (L-nitro-arginine only at reperfusion) compared with 
that in group 1 (standard blood cardioplegia) (49% + 6% vs 34% +_ 2%, 
respectively), but was not further extended in group 2 (L-nitro-arginine as 
an additive to blood cardioplegic solution and at reperfusion) (56% - 3%, 
p > 0.05 vs group 3), which suggests primarily a reperfusion process. 
Polymorphonuclear neutrophil-specific myeloperoxidase activity in the 
area at risk was elevated comparably in groups 2 and 3 (group 2:2.9 - 0.5 
units/gm tissue, p = 0.06 vs group 1; group 3:3.9 +- 1.0 units/gm tissue, p < 
0.05 vs group 1) compared with that in the standard blood cardioplegia 
group (1.7 - 0.3 units/gm tissue), suggesting polymorphonuclear neutro- 
phil accumulation occurs primarily during reperfusion. Polymorphonu- 
clear neutrophil adherence in ischemic-reperfused l ft anterior descending 
artery segments was comparably greater in group 2 (L-nitro-arginine as an 
additive to blood cardioplegic solution and at reperfusion: 195 -+ 21 
polymorphonuclear neutrophils/mm 2 of artery, p < 0.05 vs group 1) and 
group 3 (L-nitro-arginine only at reperfusion: 224 -- 20 polymorphonuclear 
neutrophils/mm 2 of artery, p < 0.05 vs group 1) relative to that in group 1 
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(108 - 19 polymorphonuelear neutrophils/mm z of artery). There was no 
significant adherence to nonischemic ircumflex arteries. We conclude that 
blockade of endogenous nitric oxide augments postischemic injury medi- 
ated by polymorphonuclear neutrophils, and this damage is expressed 
primarily during the reperfusion phase. (J Thorac Cardiovasc Surg 1997; 
113:399-409) 
L ike myocytes, the coronary endothelium falls victim to ischemia-reperfusion i jury. Under 
basal conditions, the intact vascular endothelium 
actively participates in protection of the vasculature 
by releasing nitric oxide (NO) synthesized via the I:  
arginine-NO synthase pathway, thereby functioning 
in a homeostatic capacity to prevent hrornbus for- 
mation and neutrophil adherence) However, myo- 
cardial ischemia and reperfusion impair NO pro- 
duction~ 2-5 thereby compromising this inherent 
protection. In normal myocardium, blood cardiople- 
gia largely avoids endothelial injury)' 7 However, 
ischemia-reperfusion may injure endothelium. Na- 
kanishi 8 and Dignan 9 and their associates demon- 
strated that endothelial NO-related injury does not 
occur after short periods of normothermic schemia 
alone, but that significant injury occurs after pro- 
longed ischemia or unmodified blood reperfusion. 
In ischemic hearts, this endothelial injury is not 
entirely avoided with unsupplemented blood car- 
dioplegic solutions, 8 but is reduced by an NO donor 
(SPM-5185) or L-arginine. I°' 11 However. the impor- 
tance of basally released endogenous NO m surgical 
revascularization models has not been investigated. 
This study tested the hypotheses that inhibition of 
endogenously released NO in hearts subjected to 
regional ischemia, cardioplegic arrest, and reperfu- 
sion (1) restricts endogenous cardioprotection by 
the L-arginine-NO synthase pathway and permits 
neutrophil-mediated damage and (2) expresses 
damage during the reperfusion phase in dogs sub- 
jected to 1.5 hours of regional ischemia, multidose 
blood cardioplegia, and reperfusion. 
Material and methods 
The dogs were handled in compliance with the "Guide 
for the Care and Use of Laboratory Animals" published 
by the National Institutes of Health (NIH Publication No. 
85-23, revised 1985). The institutional Animal Care and 
Use Committee approved the study protocol. 
Surgical procedure. Heartworm-free adult mongrel 
dogs of either sex weighing 18.0 to 34.5 kg (average 26.3 
kg) were initially anesthetized with intravenous sodium 
thiopental (20 mg/kg) followed by continuous infusion of 
fentanyl citrate (0.3/~g/kg per minute) and diazepam (0.03 
mg/kg per minute). Each dog was endotracheally intu- 
bated and the lungs ventilated with oxygen-enriched room 
air to maintain arterial oxygen tension values greater than 
100 mm Hg with a volume-cycled respirator (Harvard 
Apparatus. South Natick, Mass.). The right femoral artery 
and vein were cannulated for arterial blood sampling 
and fluid administration, respectively. Arterial carbon 
dioxide tension was maintained between 35 and 45 mm 
Hg by adjustment of ventilatory rate, and pH was ad- 
justed between 7.37 and 7.43 with administration of 
intravenous sodium bicarbonate as necessary. After fem- 
oral artery cannulation, peripheral blood (40 rnl) was 
collected for subsequent neutrophil isolation (see later 
section ).
Methods used for assessment of regional segmental 
function by sonomicrometry 4 and creation of collateral- 
deficient regional ischemia 12 have been presented in 
detail elsewhere. A microdialysis probe 13 for measure- 
ment of in vwo production of L-citrulline, the metabolite 
of the L-arginine-NO synthase pathway, was inserted into 
the ischemic-reperfused ! ft anterior descending (LAD) 
coronary artery. Catheter placement was confirmed at 
postmortem examination. The dogs were systemically 
heparinized with 300 U/kg heparin sodium, supplemented 
at 300 U/kg every 90 minutes. The left subclavian artery 
was cannulated for aortic perfusion. Superior and inferior 
vena caval cannulas were inserted transatrially into the 
right atrium and poised in the atrium so as not to impair 
venous return. 
Hemodynamic and segmental function data were ob- 
tained at baseline with the circulation intact, after which 
the LAD and the right ventricular branch of the LAD 
were transected to divert collateral blood flow from the 
ischemic zone. After 90 minutes of regional ischemia, 
hemodynamic and segmental function data were collected 
again. Cardiopulmonary b pass was instituted as previ- 
ously described. 14 
Experimental protocol. Dogs were randomly divided 
into three groups. In the standard blood cardioplegia 
group (SBCP group, n - 8), unmodified standard blood 
cardioplegia s was used. In the L-nitro-arginine (L-NA) 
blood cardioplegia nd reperfusion group (LNA-BR 
group, n = 7), the NO synthase blocker L-NA was 
added to blood cardioplegic solution (final concentra- 
tion of 1 mmol/L 11) and was infused intravenously (34 
mg/kg body weight) before the aortic crossclamp was 
released. In the L-NA reperfusion only group (LNA-R 
group, n = 7), L-NA was infused by intravenous injec- 
tion (34 mg/kg body weight) before the aortic cross- 
clamp was released. A previous study showed that 1 
mmol/L of L-NA blocked the endogenous release of NO 
stimulated by acetylcholine. ~1
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 2 
Sato et al. 401 
Table I. Hemodynamic data at baseline, ischemia, and reperfusion 
Baseline 90 rain of ischemia Repetfusion 
Hlq: (beats/min) 
SBCP 94 + 5 120 -+ 7 (0.02)* 136 _+ 6 
LNA-BR 103 + 11 126 ± 5 136 _+ 12 
LNA-R 110 + 12 136 + 10 135 -+ 9 
MAP (mm Hg) 
SBCP 85 + 6 84 _+ 4 82 ± 4 
LNA-BR 83 ± 5 81 ± 7 74 _+ 4 
LNA-R 81 ± 6 83 -+ 4 76 ± 4 
PRP (mm Hg/min × 10 3) 
SBCP 9.2 -~_ 0.7 10.8 ± 0.7 13.2 + 0.9 (0.03*) 
LNA-BR 10.1 ± 1.5 10.2 ± 1.3 11.8 -+ L0 (0.05*) 
LNA-R 10.2 ± 1.5 12.5 + 1.4 12.2 _+ 0.9 
Values represent means plus or minus the standard error of the estimate. HR, Heart rate; MAP, mean arterial pressure; PRP, pressure-rate product. 
*p Value versus previous period. 
Table IL Blood cardioplegic solution delivery volume in milliliters 
Group Warm induction Cold induction 20-rain infusion 40-rain infusion Terminal 
SBCP 405 -£ 36 254 _+ 33 (0.01") 175 +- 19 (0.02*) 165 ± 19 275 _+ 51 (0.01") 
LNA-BR 372 + 31 245 _+ 41 (0.03*) 189 + 36 (0.02*) 158 _+ 41 240 _+ 57 (0.02*) 
LNA-R 369 + 23 233 _+ 33 (0.03*) 215 _+ 15 165 +- 22 281 ± 31 (0.01") 
Values are given as means plus or minus the standard error of the estimate. 
*p VaIue versus previous period. 
Cardioplegic arrest. After 90 minutes of LAD occlu- 
sion, the aorta was crossclamped, and blood cardiople- 
gic solution was delivered intermittently (every 20 
minutes) at 50 mm Hg pressure by the warm-cold 
induction modality ~5 with terminal warm infusion. Be- 
fore the 20-minute delivery of cardioplegic solution, the 
LAD vesse ! loop was removed and the arteriotomy for 
collateral diversion was closed. Systemic temperature 
was maintained at 28 ° C. 
At the end of 1 hour of arrest, systemic rewarming to 
37°C was achieved, and the crossclamp was removed. 
Mean aortic pressure was gradually increased from 50 mm 
Hg to 80 mm Hg after electromechanical reanimation. 
The heart was maintained in vented bypass for the initial 
30 minutes of reperfusion. After systemic blood Ca 2+ 
content was corrected to baseline values, 16 the dog was 
weaned off bypass and allowed to support he circulation 
for an additional 30 minutes in the working state. After 
postischemic measurements were made, the heart was 
excised and immediately immersed in cold Krebs-Hense- 
leit solution with the following composition (in millimo- 
lars per liter): 118 NaCI, 4.7 KC1, 1.2 KH2PO4, 1.2 
MgSO4, 2.5 CaCla, 12.5 NaHCO3, and 10 glucose. The 
ischemic-reperfused LAD and the nonischemic left cir- 
cumflex coronary artery (LCx) were carefully isolated, and 
artery segments were removed and placed in cold, oxy- 
genated Krebs-Henseleit solution. 
Determination of area at risk and infarct size. The 
interrupted LCx was bridged with a polyethylene tube 
to reestablish continuity, and gentian violet dye was 
perfused through the aortic root to stain the normally 
perfused region blue. The area at risk was demarcated 
by the lack of blue staining. The area of necrosis and 
infarct size were determined by triphenyltetrazolium 
chloride vital stain and gravimetric analysis as previ- 
ously described. 4'17 
Data acquisition and analysis. Hemodynamic data 
were acquired and processed by computer as detailed 
previously. 4't8 Hemodynamic and cardiodynamic data 
were averaged from no fewer than 15 beats. The pressure- 
rate product, percent segmental shortening, segmental 
work, and diastolic segmental stiffness were determined as 
previously described. 4 
In vitro coronary artery studies. Plasma creatine ki- 
nase activity, cardiac myeloperoxidase activity, and coro- 
nary reactivity were measured as described previous- 
ly.11, 12 In addition, the heart was excised from five normal 
dogs to obtain control data. Neutrophils were isolated and 
adherence to the coronary artery segments was deter- 
mined as previously detailed. 19 
In vivo estimation of local NO production. Estimation 
of NO production by cardia c microdialysis was modified 
from the method described by Northington and associ- 
ates, 2° in which L-arginine is converted to an equimolar 
concentration of L-citrulline and NO by the action of NO 
synthase. Three micromolars of L-[14C]arginine (Dupont/ 
NEN, Boston) was prepared in fresh Krebs-Henseleit 
buffer. After 1 hour of stabilization, the mierodialysis 
buffer was replaced with L=[14C]arginine solution and 
constantly perfused at 2 ~l/min. Dialysate samples were 
collected every 30 minutes (60 ~1 in each sample) and 
diluted in 200 ~1 of 30 mm01 N-2-hydroxyethylpiperazine- 
N'-2-ethane-sulfonic a id buffer (pH 5.5) containing 3 
mmol ethylenediaminetetraacetic acid and applied to a 
chromatography column of 0.5 ml Dowex AG-50WX8 
resin (Na ÷ form, pH 7.0, Sigma Chemical Co., St. Louis, 
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Fig. 1. Segmental shortening (top panel) and segmental work (bottom panel) in ischemic-reperfused zone 
at baseline (CTRL, control), at the end of coronary occlusion (ISCH, ischemia), and after 60 minutes of 
reperfusion (REP) in the working heart. Bar heights represent mean plus or minus the standard error of the 
mean. There were no significant differences among the three groups. 
,.., 5- 
4-  
. m  
e-, 
3" 
II1 
2- 
o 
I]J 
0 
-4 -  SBCP 
.-e- LNA-BR 
l LNA-R 
I I I 
CTRL ISCH REP 
Fig. 2. Segmental stiffness, indexed as/3-coefficient or modulus of stiffness derived from the exponential 
end-diastolic pressure-segment length relationship. Value of/3 in SBCP group was significantly less than 
that in the other two groups at reperfusion. Symbol heights represent mean plus or minus the standard error 
of the mean. CTRL, Control; ISCH, ischemia; REP, reperfusion. *p < 0.05 versus other two groups; ?p < 
0.05 versus previous value. 
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Table III. Segmental length data for ischemic-reperfused gment 
Baseline 90 rain of ischernia Reperfusion 
EDL (mm) 
SBCP 13.0 ± 1.1 16.5 -+ 1.4 (0.03*) 13.1 ± 1.1 (0.03*) 
LNA-BR 15.1 +- 1.5 18.5 -+ 1.4 (0.03*) 14.5 ± 1.5 (0.04*) 
LNA-R 12.5 ± 0.7 15.3 ± 0.7 (0.04*) 12.1 _+ 0.8 (0.04*) 
ESL (rnm) 
SBCP 10.9 ± 1.0 17.8 ± 1.4 (0.01") 12.8 ± 1.1 (0.03*) 
LNA-BR 13.0 ± 1.3 19.5 -+ 1,4 (0.02*) 14.3 ± 1.5 (0.02*) 
LNA-R 10.9 ± 0.9 16.2 _+ 0,7 (0.02*) 12.1 4-_ 0.8 (0.03*) 
Values are given as means plus or minus the standard error of the estimate. EDL, End-diastolic length; ESL, end-systolic length. 
*p Value versus previous period. 
Table IV. Plasma creatine kinase activity (international tmits per gram protein) during the time course of the 
experiment 
Reperfusion 
Group Preischemia Ischemia Blood cardioplegia BE B W 
SBCP 1.15 ± 0.29 3.77 -+ 0.64* 6.35 ± 0.89* 10.93 ± 1.35" 17.33 -+ 1.96"I" 
LNA-BR 1.32 ± 0.40 7.30 ± 1.65"? 13.63 ± 3.92*$ 24.32 ± 7.24 38.63 + 9.78" 
LNA-R 1.09 ± 0.21 4.04 ± 0.43* 7.40 + 1.01" 18.81 ± 3.69* 29.96 ± 3.44* 
Values are given as means plus or minus the standard error of the estimate. BE, Beating empty,; BW,, beating working. 
~p < 0.05 versus previous period. 
+p <0.05 versus other two groups. 
Sp < 0.05 versus SBCP group. 
Mo.). L-[14C]citrulline was eluted with 2 ml buffer and 
quantified by liquid scintillation (LKB 1219, Rakebete, 
Md.). L-[14C]citrulline activity obtained from each dialy- 
sate sample was expressed as percent of baseline value. 
Statistical analysis. All data were analyzed with the 
Statistical Analysis System program (PC-SAS, SAS Insti- 
tute, Cary, N.C.). Time-related ifferences and group- 
time interactions were analyzed by two-way analysis of 
variance for repeated measures. Infarct size and myelo- 
peroxidase activity were analyzed by one-way analysis of 
variance. Vascular responses were expressed as percent 
changes of tension from the precontracted levels and 
compared by one-way analysis of variance. The close of the 
drug required to effect relaxation to 50% of maximum 
precontracted levels (ECso) was calculated and expressed 
as the negative log of the drug concentration. All data are 
presented as means plus or minus the standard error of 
the mean. 
Results 
Twenty-two dogs (SBCP group, 8; LNA-BR 
group, 7; LNA-R group, 7) were entered into the 
final data analysis of infarct size and regional func- 
tion. 
Hemodynamies, myocardial temperature, and 
cardioplegic solution volume. Blood gas data be- 
fore bypass and after stabilization on bypass were 
not significantly different among the groups. There 
were no group differences in the number of cardio- 
versions required during the early period of reper- 
fusion (SBCP group, 5; LNA-BR group, 4; LNA-R 
group, 5). 
Hemodynamic data for the three groups at base- 
line and during ischemia and reperfusion are sum- 
marized in Table I. There were no group differences 
in any of the parameters at baseline. During coro- 
nary occlusion, heart rate was significantly increased 
from the baseline value only in the SBCP group. 
However, there were no group differences in any of 
the parameters during ischemia. During reperfu- 
sion, pressure rate product increased significantly 
from values during ischemia in the SBCP and 
LNA-BR groups, but with no group differences at 
that time. 
There were no significant differences among the 
three groups in blood cardioplegic solution compo- 
sition (pH, oxygen tension, osmolality, hematocrit), 
delivery volume, or myocardial temperatures (Table 
II). 
Segmental systolic and diastolic function. There 
were no group differences in segmental systolic or 
diastolic function at baseline (Table III). Ischemia 
caused paradoxic systolic expansion so that the 
end-systolic length exceeded the end-diastolic 
length in all groups. Both the magnitude of segmen- 
tal shortening and segmental work (Fig. 1) showed 
similar dyskinesis in all three groups. Segmental 
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Fig. 3. Mass of the area at risk versus mass of left 
ventricle as percentage (Ar/LV, top panel), mass of the 
area of necrosis versus mass of left ventricle as percentage 
(An/LV,, middle panel), and area of necrosis as percent of 
area at risk (An/Ar, bottom panel). Although the area 
placed at risk was comparable among roups, the areas of 
necrosis as percent of area at risk was significantly in- 
creased in LNA-BR and LNA-R groups relative to that in 
SBCP group. Bats represent mean plus or minus the 
standard error of the mean; circles represent individual 
values for each group. *p < 0.05 versus SBCP group. 
shortening and work were depressed uring reper- 
fusion, with no group differences. 
The/3-coefficient (modulus of diastolic segmental 
stiffness) data of the exponential end-diastolic pres- 
sure-segment length relation are summarized in Fig. 
2. LAD occlusion did not increase the segmental 
stiffness in the area at risk to values greater than 
baseline in any of the three groups. During reper- 
fusion, segmental stiffness was significantly in- 
creased to greater than that during ischemia in all 
three groups. However, the ~-coelticients in the 
LNA-BR and LNA-R groups were significantly 
greater than those in the SBCP group. 
Area at risk and infarct size. The masses of the 
left ventricle and area at risk were similar among the 
groups, as was the percentage area at risk (Fig. 3, top 
panel). The area of necrosis, expressed as a percent- 
age of the area at risk, shown in Fig. 3, bottom panel, 
was significantly increased in both L-NA-treated 
groups compared with the SBCP group. Therefore 
blockade of the endogenous L-arginine-NO pathway 
by L-NA exacerbated infarct size presumably by 
inhibiting production of endogenous NO. 
Plasma creatine kinase activity. There was no 
significant difference in plasma creatine kinase ac- 
tivity at baseline among the three groups (Table IV). 
All three groups showed a significant increase in 
plasma creatine kinase activity during LAD occlu- 
sion to the end of the experiment. Creatine kinase 
activity increased ramatically during the cardiople- 
gia period in the three groups, but was significantly 
greater in the LNA-BR and LNA-R groups than in 
the SBCP group. The significantly greater creatine 
kinase activities in the two groups that received L- 
NA were consistent with the larger infarct sizes 
relative to those in the SBCP group. 
Cardiac myeloperoxidase activity. Myeloperoxi- 
dase activity in the nonischemic zone (Fig. 4) was 
comparably low among the SBCP, LNA-BR, and 
LNA-R groups. Myeloperoxidase activity in the 
ischemic but nonnecrotic zone increased signifi- 
cantly over values in the nonischemic zone in the 
three groups. However, myeloperoxidase activity in 
the LNA-R group was significantly greater by 
132.4% than that in the SBCP group. Also, there 
was a strong tendency (p = 0.06) for the LNA-BR 
group to have greater myeloperoxidase activity com- 
pared with that in the SBCP group. However, in the 
necrotic zone, myeloperoxidase activity in the three 
groups was less than that in the ischemic nonne- 
crotic zone without differences among the three 
groups. 
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Fig. 4. Myeloperoxidase (MPO) activity in nonischemic zone (NIZ), ischemic but nonnecrotic zone (IZ), 
and ischemic-necrotic zone (NEC). Myeloperoxidase activity was significantly less in SBCP group in 
ischemic but nonnecrotic zone. Bar heights represent mean plus or minus the standard error of the mean. 
*p < 0.05 versus SBCP group; tp = 0.06 versus SBCP group. 
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Fig. 5. Dialysate interstitial L-[14C]citrulline concentration in area at risk (percent change of control 
value). Citrulline level was significantly higher in SBCP group at the end of reperfusion. Symbol heights 
represent mean plus or minus the standard error of the mean. PRE, Preischemia; ISCHI, first 30 minutes 
of occlusion; ISCH2, 30 to 60 minutes of occlusion; ISCH3, 60 to 90 minutes of occlusion; BCP1, first 30 
minutes of blood cardioplegic arrest; BCP2, 30 to 60 minutes of blood cardioplegic arrest; BE, 30 minutes 
of beating empty period; BW,, 30 minutes of beating working period. *p < 0.05 versus other two groups; "~p 
< 0.05 versus previous period. 
In vivo local NO production. L@4C]citrulline ac- 
tivity obtained from intramyocardial microdialysis 
was expressed as a percent of the preischemic value 
and results are shown in Fig. 5. During the coronary 
occlusion, local NO production was significantly 
increased in all three groups with no group differ- 
ences. During blood cardioplegic arrest, the L- 
[14C]citrulline levels tended to decrease in the two 
groups receiving i, -NA. During reperfusion, the L- 
[i4C]citrulline level in the L-NA-treated groups was 
significantly less than that in the SBCP group. These 
data confirm that L-NA inhibited NO synthase ac- 
tivity in the treated groups. 
In vitro coronary artery data 
NeutrophiI adherence assay. Adherence of un- 
stimulated polymorphonuclear  leukocytes to isch- 
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Fig. 6. Adherence of unactivated polymorphonuclear 
leukocytes (PMNs) to the endothelium of normal coro- 
nary arterial ring segments (CTRL), ischemic-reperfused 
LAD ring segments from each group (SBCP L, LNA-BR 
L, LNA-R L, where L indicates LAD), and LCx ring 
segments from each group (SBCP C, LNA-BR C, LNA-R 
C, where C indicates LCx). Polymorphonuclear leukocyte 
adherence toLAD segments was significantly increased in
all three groups. However, adherence in L-NA-treated 
groups was significantly higher than that in the SBCP 
group. There was no increase in adherence and no group 
differences in LCx ring segments. Bar heights represent 
mean plus or minus the standard error of the mean; 
numbers in bars represent numbers of coronary arterial 
ring segments studied. *p < 0.05 versus other groups. 
emic-reperfused coronary artery segments i used as 
an index of basal NO release. When unstimulated 
polymorphonuclear leukocytes were coincubated 
with normal unstimulated coronary endothelium as 
a control observation, very little adherence of neu- 
trophils was observed (Fig. 6). However, in the 
ischemic-reperfused LAD segments, neutrophil ad- 
herence was significantly increased in the SBCP 
group, suggesting loss of NO production by the 
endothelium. In addition, L-NA treatment signifi- 
cantly increased neutrophil adherence further com- 
pared with that in the control LAD segment and the 
SBCP group. In contrast, adherence to nonischemic- 
reperfused LCx segments from each group was 
similar to that in unstimulated control arteries (Fig. 6). 
Agonist-stimulated coronary artery relaxation data. 
The optimal passive length determined from length- 
tension responses to potassium chloride in the LAD 
and LCx was comparable among all groups. 
Endothelium-dependent relaxations. Fig. 7 shows 
vasodilator responses to acetylcholine (upper panel) 
in the LAD and LCx rings. The concentration 
response curve in LAD rings in the SBCP group was 
shifted markedly to the right compared with that in 
the control group, involving a decrease in maximal 
response and an increase in the ECs0 (6.99 + 0.05 vs 
7.68 _+ 0.03 -log[mol] in control group). However, 
the shift in the curves for the LNA-BR (6.26 _+ 0.04) 
and LNA-R (6.44 _+ 0.05) groups was significantly 
greater than that in the SBCP group. The concen- 
tration response curves to acetylcholine in the LCx 
rings from all three groups were also markedly 
shifted to the right relative to those in the control 
group. The rightward shift in the SBCP group was 
more modest (7.29 _+ 0.15) than that in rings from 
the LAD in the same group. However, marked shifts 
indicative of endothelial damage occurred in the 
LNA-BR (6.23 _+ 0.06) and LNA-R (6.27 _+ 0.06) 
groups relative to control LCx values (7.68 _+ 0.03). 
The concentration responses to A23187 in LAD 
and LCx rings were similar in both L-NA-treated 
groups to those observed for acetylcholine (Fig. 7, 
center panel) except hat the rightward shift for the 
SBCP group was less pronounced. There were no 
group differences in the maximum relaxation among 
all four groups. ECs0 values in the LAD rings were 
significantly greater in the SBCP (7.65 _+ 0.07 
-log[mol]), LNA-BR (7.05 + 0.09), and LNA-R 
(7.14 _+ 0.04) groups than in the control arteries 
(7.84 _+ 0.04), consistent with a rightward shift. ECs0 
values in the LCx rings were similar in the control 
(7.84 _+ 0.04) and SBCP (7.79 _+ 0.07) groups and 
increased in the LNA-BR (7.26 _+ 0.04) and LNA-R 
(7.33 _+ 0.06) groups, consistent with the greater 
rightward shift in these two groups. 
Endothelium-independent smooth-muscle relax- 
ations. Acidified sodium nitrite was used to induce 
endothelium-independent r laxation (Fig. 7, bottom 
panel). The concentration response curves in LAD 
rings from the SBCP (ECs0 values 5.04 + 0.06 
-log[mol]), LNA-BR (4.77 _+ 0.06), and LNA-R 
(4.99 _+ 0.07) groups were markedly shifted to the 
right compared with the curve from the control 
group (5.49 _+ 0.05), without a reduction in the 
maximum relaxation compared with that in the 
control group. However, the shift was significantly 
greater in the LNA-BR group than in the SBCP and 
LNA-R groups. In the LCx rings, there were no 
significant differences in the relaxation responses 
among all three groups (ECs0 in SBCP group, 
5.41 _+ 0.12; LNA-BR group, 5.20 _+ 0.09; LNA-R 
group, 5.37 _+ 0.11) compared with control values 
(5.49 _+ 0.05). 
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Discussion 
In the present study, we found that inhibition of 
endogenous NO release increased infarct size by 
62.5% in the LNA-BR group (combination of blood 
cardioplegia nd reperfusion) and by 42.6% in the 
LNA-R group (reperfusion only), compared with 
results with an unsupplemented blood cardioplegic 
solution. In addition, I.-NA treatment increased 
diastolic segmental stiffness in the ischemic-reper- 
fused segment, increased neutrophil accumulation 
in the ischemic-reperfused myocardium, and exac- 
erbated neutrophil adherence to the ischemic-reper- 
fused coronary artery segment, consistent with a loss 
of basal NO release. L-NA reduced basal endothelial 
function in ischemic-reperfused LAD segments but 
not in normal LCx segments. Our data suggest that 
the actions of L-NA were exerted primarily during 
blood reperfusion (aortic deciamping) because the 
LNA-BR group did not significantly extend isch- 
emia-reperfusion injury further compared with that 
in the LNA-R group. 
Both basal endothelial function and stimulated 
vasodilator responses were depressed in ischemic- 
reperfused LAD segments. The depression in ago- 
nist-stimulated endothelial vasodilator esponses 
was modest in the standard unsupplemented blood 
cardioplegia group and may reflect some degree of 
smooth muscle damage (Fig. 7). Endothelium-de- 
pendent vasodilator responses were more severely 
depressed in the L-NA-treated groups. Although 
this observation is consistent with ischemia-reperfu- 
sion-induced endothelial damage reported in other 
studies,S, 8, 10, 11 similar results may be observed with 
a persistent effect of L-NA independent of endothe- 
lial injury. We have previously observed a blunted 
agonist (acetylcholine)-stimulated r laxation re- 
sponse in control coronary arteries treated with 
L-NA, despite a prolonged washout period of up to 
2 to 3 hours. 11 Blunted responses were also observed 
in the LCx in the present study, although these 
vessels encountered only global cardiac arrest. It is 
possible that L-NA could cause a persistent or 
irreversible inhibition of agonist-stimulated NO re- 
lease while having no effect on basal NO. The exact 
mechanism of this effect is not known but may 
involve (1) different compartments of basal and 
pharmacologically stimulated NO, (2) a limitation of 
stimulated NO release to that required to achieve 
basal evels, or (3) a partial inhibition of the musca- 
rinic receptor by L-NA. Therefore, in this study, the 
agonist stimulator esponse assay cannot discrimi- 
nate between NO synthase inhibition with I.-NA or 
endothelial injury in the circumflex coronary arter- 
ies. 
In summary, the present study demonstrates that 
inhibition of endogenous NO synthase activity by I.- 
NA administered in blood cardioplegic solution and 
during reperfusion, or during reperfusion only, is 
associated with a significant increase in infarct size 
and regional diastolic dysfunction. Also, L-NA treat- 
ment was associated with an increase in neutrophil 
accumulation within the area at risk. Inhibition of 
NO synthase-mediated protection may have also 
damaged both the coronary vascular endothelium 
and to a lesser extent he vascular smooth muscle. 
These data are consistent with the hypothesis that 
endogenous NO participates in the inherent protec- 
tion of the ischemic-reperfused and the normal 
myocardium during cardiac operations. These data 
provide a rationale for implementing proactive pro- 
tective strategies that target protection of the vas- 
cular endothelium. 
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Discuss ion 
Dr. Robert A. Guyton (Atlanta, Ga.). I would like a little 
clarification of the time course of the neutrophil adher- 
ence. The proponents of leukocyte depletion claim that a 
temporary depletion of leukocytes will prevent damage to 
the ischemic area because the vessels are restored to 
normal and leukocyte adherence is not increased after 10 
or 15 minutes. What was the time course of the testing of 
these isolated arteries? 
Dr. Sato. The coronary arteries were excised from the 
area at risk representing ischemic-reperfused v ssels and 
from the nonischemic zone at the end of reperfusion in 
each experiment. The postexperimental coronary artery 
segments were then incubated with autologous neutro- 
phils obtained from the same animal the day of the 
experiment. Postreperfusion neutrophil adherence to 
the endothelium of these coronary arteries is therefore 
an index of damage to basal NO release by the endo- 
thelium. 
Dr. Guyton. These arteries were excised and tested 
after 60 minutes of reperfusion? 
Dr. Sato. Yes. this was done after reperfusion, at the 
end of the experiment. 
Dr. Neil K. Worrall (St. Louis. Mo.). Agents such as 
nitro-argimne are very potent constitutive NO synthase 
inhibitors and therefore act as vasoconstrictors, and in this 
study, at the doses that were used. there probably would 
have been a reduction in blood flow to the myocardium. 
Did the authors measure blood flow in the study? 
Dr. Sato. No. we did not measure myocardial blood 
flow. We did measure blood cardioplegic solution volumes 
to determine whether vasoconstriction i duced by N °,_ 
nitro-L-arginine methyl ester may have impaired adequate 
delivery of blood cardioplegic solution, but did not find 
any group differences. However, to what extent postisch- 
emic vasoconstriction contributed to depressed function 
or other pathophysiologic mechanisms is not clear. 
Dr. Richard M. Engelman (Springfield, Mass.). The 
authors have previously shown that L-arginine benefits the 
heart when administered in the cardioplegic solution. 
Have they attempted to see whether L-arginine reverses 
the effect that was found with N~-nitro-L-arginine m thyl 
ester when it was just given during reperfusion? 
Dr. Sato. No, we did not try to reverse the effects of 
N°'-nitro-L-arginine methyl ester with L-arginine in this 
experiment. However, we have done this in other experi- 
ments, which have shown that neutrophil accumulation, 
neutrophil-mediated damage, and increased adherence to 
endothelium observed with N'°-nitro-L-arginine methyl 
ester can be reversed by L-arginine, thereby substantiating 
the NO synthase pathway. 
